EUPRAXIA PHARMACEUTICALS INC (EPRX) Stock Cash Flow
NASDAQ:EPRX - Nasdaq - CA29842P1053 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -26.35M | -25.74M | -28.97M | -23.92M | -23.37M | |||
| Depreciation Amortization | 135.60K | 114.00K | 112.90K | 190.00K | 110.00K | |||
| Change In Working Capital | -7.72M | -6.76M | 5.35M | 2.07M | -210.00K | |||
| Interest Paid | N/A | 393.70K | 598.10K | N/A | N/A | |||
| Other non cash items | 4.06M | 2.40M | 2.75M | 2.87M | 8.83M | |||
| OPERATING CASH FLOW | -29.88M | -29.99M | -20.75M | -18.78M | -14.64M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -266.40K | -104.20K | -73.40K | -310.00K | -430.00K | |||
| Other Investing Activity | N/A | 29.10K | 0.00 | 9.01M | -14.02M | |||
| INVESTING CASH FLOW | -237.40K | -75.20K | -73.40K | 8.70M | -14.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -9.14M | -79.40K | -190.00K | 12.08M | |||
| Stock Issued/Repurchased | 32.16M | 54.92M | 21.16M | 13.71M | 37.83M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 23.06M | 45.78M | 21.08M | 13.52M | 49.92M | |||
| Exchange Rate Effect | -1.40M | -1.96M | 821.40K | 400.00K | -80.00K | |||
| CHANGE IN CASH | -8.45M | 13.76M | 1.08M | 3.84M | 20.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.88M | -29.99M | -20.75M | -18.78M | -14.64M | |||
| Capital Expenditure | -266.40K | -104.20K | -73.40K | -310.00K | -430.00K | |||
| FREE CASH FLOW | -30.14M | -30.10M | -20.82M | -19.09M | -15.07M | |||
All data in USD